ClinConnect ClinConnect Logo
Search / Trial NCT06837220

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Launched by UNIVERSITY OF CHICAGO · Feb 14, 2025

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Smoking Smoking Cessation Nicotine Nicotine Use Disorder Quitting Smoking Quitting Nicotine Respiratory Health Telehealth Virtual Tobacco Tobacco Treatment Community Behavioral Health Chicago Group Therapy Disparities Adults Who Smoke Cigarettes Tobacco Cessation Cessation Abstinence Substance Use Substance Abuse Addiction Counseling Health Counseling Health Communication

ClinConnect Summary

This clinical trial is focused on helping people quit smoking by understanding the challenges they face and finding better ways to support them. The study will work with local health organizations in Chicago to gather insights from both healthcare leaders and adults who smoke. A community advisory board will be created to guide the research, and a trial smoking cessation program will be tested to see how well it works and fits into the community.

To participate in this study, you need to be at least 18 years old, currently smoke at least one cigarette a day, and be interested in quitting smoking. You should also be able to understand English and have a stable living situation in Chicago during the study. Unfortunately, if you smoke only occasionally or don’t want to quit, you wouldn’t be eligible. Throughout the trial, participants can expect support and resources aimed at helping them stop smoking, and their feedback will help shape future smoking cessation programs in the community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month
  • Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting)
  • Age 18 or older, ability to understand the English language, willing and able to provide informed consent
  • Stable residence and contact information throughout the follow up period
  • Exclusion Criteria:
  • Non-daily or intermittent cigarette use
  • No interest in quitting smoking
  • Unstable residence/not staying in Chicago for duration of study period
  • Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g. schizophrenia, bipolar disorder, obsessive compulsive disorder, unspecified psychosis, past-year suicide attempt)

About University Of Chicago

The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported